Concepedia

Mark Zielstorff

MZ

Statistics

Publications

6

Citations

247

H-Index

6

Active since

2014

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

Mark Zielstorff is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, immunology, and medicine.

ORCID

Publications per year

2014–2018

6

Publications

6

A multiplexed microfluidic system for evaluation of dynamics of immune–tumor interactions

Nathan W. Moore, Daniel Doty, Mark Zielstorff et al. · Lab on a Chip · 2018 · 101 citations

, , +17

Development of Anti-CD74 Antibody–Drug Conjugates to Target Glucocorticoids to Immune Cells

Philip E. Brandish, Anthony Palmieri, S. V. Antonenko et al. · Bioconjugate Chemistry · 2018 · 58 citations

, , +17

Evaluation of JAK3 Biology in Autoimmune Disease Using a Highly Selective, Irreversible JAK3 Inhibitor

Fiona Elwood, David J. Witter, Jennifer Piesvaux et al. · Journal of Pharmacology and Experimental Therapeutics · 2017 · 32 citations

, , +14

Development and optimization of a high-throughput micro-computed tomography imaging method incorporating a novel analysis technique to evaluate bone mineral density of arthritic joints in a rodent model of collagen induced arthritis

Raquel Sevilla, Francisco Cruz, Chi‐Sung Chiu et al. · Bone · 2014 · 27 citations · Full text

, , +17

Etanercept ameliorates inflammation and pain in a novel mono-arthritic multi-flare model of streptococcal cell wall induced arthritis

Kalyan Chakravarthy, Robert Faltus, Gain Robinson et al. · BMC Musculoskeletal Disorders · 2014 · 17 citations · Full text

, , +16

1–5 of 6